EE153 Cost-Minimization of Oral Valganciclovir Vs Intravenous Ganciclovir for Cytomegalovirus Prophylaxis in Renal Transplant Recipients
| Autor: | Alves, Junior JM, Prota, FE, Martinelli, JCB, Chrispim, A, Christoforo, FF, Serpeloni, M, Barreto, I, da Silva AC |
|---|---|
| Zdroj: | In Value in Health June 2024 27(6) Supplement:S85-S85 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|
Full Text from ScienceDirect